Abbott Laboratories (ABT)’s Molecular Test For Detecting Zika Virus Approved By The FDA
The Abbott RealTime ZIKA molecular test from Abbott Laboratories (NYSE:ABT) has gained the approval of the U.S. Food and Drug Administration (FDA).
Posts Tagged ‘Is ABT A Good Stock To Buy Right Now?’
Abbott Laboratories (ABT) Pacemakers Get FDA Approval
The Tendril MRI pacing lead and the Assurity MRI pacemaker have been approved by the U.S. Food and Drug Administration.
ACCURATE Study Confirms Superiority Of Abbott Laboratories (ABT) Dorsal Root Ganglion (DRG) Stimulation
Abbott Laboratories (NYSE:ABT)'s dorsal root ganglion (DRG) stimulation therapy has advantages over traditional spinal cord stimulation (SCS) in the treatment of patients suffering...
Alinity ci-series Of Diagnostic Systems From Abbott Laboratories (ABT) Obtains CE Mark
Alinity, a family of next-generation clinical chemistry and immunoassay diagnostics from Abbott Laboratories (NYSE:ABT) is now being offered in Europe and other countries that...
Dividend Growth Stocks For Further Research
Each week I review the list of dividend increases as part of my monitoring process.
Abbott Laboratories (ABT) Dragging Alere Inc (ALR) To Court
Abbott Laboratories (NYSE:ABT) has sued Alere Inc (NYSE:ALR), a diagnostics company it agreed to acquire earlier this year, for breach of contract.
This Health Care Dividend Aristocrat Will Profit From Old Age – Globally
The world is aging. The average global population age is increasing.
Source: The Economist
This means there are more middle-aged and elderly people than ever before. This trend is expected to continue far into the future.
Dividend Aristocrats Part 30: Abbott Laboratories (ABT)
Abbott Laboratories has been wildly successful in its long history. The company’s success is not a historical relic; Abbott has positioned itself well to take advantage of...
